EOLS - Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript
2025-08-05 19:15:46 ET
Evolus, Inc. (EOLS)
Q2 2025 Earnings Conference Call
August 05, 2025, 04:30 PM ET
Company Participants
David Moatazedi - President, CEO & Director
Nareg Sagherian - Head of Global Investor Relations & Corporate Communications
Rui Avelar - Chief Medical Officer and Head of Research & Development
Conference Call Participants
Annabel Eva Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
Douglas Dylan Tsao - H.C. Wainwright & Co, LLC, Research Division
Marc Harold Goodman - Leerink Partners LLC, Research Division
Navann Ty Dietschi - BNP Paribas Exane, Research Division
Sam Shimon Eiber - BTIG, LLC, Research Division
Serge D. Belanger - Needham & Company, LLC, Research Division
Uy Sieng Ear - Mizuho Securities USA LLC, Research Division
Presentation
Operator
Good afternoon, everyone, and thank you for standing by. Welcome to Evolus' Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded and webcast live. [Operator Instructions] I would now like to turn the conference over to Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead....
Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript